Navigation Links
Executive Order on Embryonic Stem Cells 'A Sad Victory of Politics Over Science and Ethics,' Says Cardinal Rigali
Date:3/9/2009

WASHINGTON, March 9 /PRNewswire-USNewswire/ -- Cardinal Justin Rigali, chairman of the U.S. Conference of Catholic Bishops' Committee on Pro-Life Activities, today called President Obama's executive order on embryonic stem cell research "a sad victory of politics over science and ethics." Under the order, for the first time in U.S. history, federal tax dollars will be used to encourage researchers to destroy live human embryos for stem cell research. Cardinal Rigali also cited a January 16 letter in which Cardinal Francis George, president of the USCCB, urged President-elect Obama not to issue such an order. Cardinal Rigali's statement follows:

"President Obama's new executive order on embryonic stem cell research is a sad victory of politics over science and ethics. This action is morally wrong because it encourages the destruction of innocent human life, treating vulnerable human beings as mere products to be harvested. It also disregards the values of millions of American taxpayers who oppose research that requires taking human life. Finally, it ignores the fact that ethically sound means for advancing stem cell science and medical treatments are readily available and in need of increased support.

"In his January 16th letter to President-elect Obama, Cardinal George, writing as President of the USCCB, cited three reasons why such destructive research is 'especially pointless at this time':

  • 'First, basic research in the capabilities of embryonic stem cells can be and is being pursued using the currently eligible cell lines as well as the hundreds of lines produced with nonfederal funds since 2001.
  • 'Second, recent startling advances in reprogramming adult cells into embryonic-like stem cells - hailed by the journal Science as the scientific breakthrough of the year - are said by many scientists to be making embryonic stem cells irrelevant to medical progress.
  • 'Third, adult and cord blood stem cells are now known to have great versatility, and are increasingly being used to reverse serious illnesses and even help rebuild damaged organs. To divert scarce funds away from these promising avenues for research and treatment toward the avenue that is most morally controversial as well as most medically speculative would be a sad victory of politics over science.'

"If the government wants to invest in hope for cures and promote ethically sound science, it should use our tax monies for research that everyone, at every stage of human development, can live with."


'/>"/>
SOURCE U.S. Conference of Catholic Bishops Secretariat for Pro-Life Activities
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. University of Maryland Business School Continues Executive Education Leadership With Maryland State Medical Society Partnership
2. Pelosi Statement on President Obamas Executive Order on Stem Cell Research
3. Reveille Software Reaches Customer Milestone and Expands Executive Team
4. Embryonic Stem Cell Research Executive Order Places Politics Ahead of Science, Says Michigan Catholic Conference
5. National Patient Advocate Foundation Announces 2009 Elections of Health Policy Leaders to Executive Board of Directors
6. It Must Be Friday Night: Pres. Obama to Issue Deadly Executive Order
7. HMS Holdings Corp. Announces Executive Promotions
8. RoundTable Appoints Senior Healthcare Executives
9. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Authentidate Holding Corp.
10. Authentidate Holding Corp. Non-executive Chairman F. Ross Johnson Steps Down From Board of Directors
11. Statement by Robert Greenstein, Executive Director, Center on Budget and Policy Priorities, on the Presidents 2010 Budget Proposal
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2017)... Wisconsin (PRWEB) , ... May 24, 2017 , ... ... in clean label food ingredient solutions for the food and beverage industry offers ... in food ingredient statements during the purchasing decision process. As a result, labels ...
(Date:5/23/2017)... (PRWEB) , ... May 23, 2017 , ... ... Population Health and Clinical Integration company, announced today that its iClinic V12.2 solution ... (PCMH) 2017 Prevalidation. NCQA recently introduced PCMH 2017 standards which emphasize team-based ...
(Date:5/23/2017)... YORK, NY (PRWEB) , ... May 23, 2017 ... ... makers in the pharmaceutical and medical device sectors, today announced the winners of ... Transformers • Entrepreneurs) represent the most influential people in the healthcare industry today. ...
(Date:5/23/2017)... Santa Rosa, California (PRWEB) , ... May 23, ... ... population health management (PHM) technology and a 2017 Best in KLAS category winner, ... an advantageous market position to extend and enhance its technology platform and product ...
(Date:5/23/2017)... ... May 23, 2017 , ... The ... Dr. Kevin Sadati, is pleased to announce a new treatment option called Vivace ... in their face, neck, and body through a virtually pain-free, non-surgical treatment. Vivace ...
Breaking Medicine News(10 mins):
(Date:5/6/2017)... May 5, 2017  Hill-Rom Holdings, Inc. (NYSE: HRC), ... 100,000 square feet to its Welch Allyn campus. ... commitment to bring more than 100 new jobs to ... Allyn has maintained a significant presence for more than ... new positions, a large portion of which will be ...
(Date:5/4/2017)... May 4, 2017  A recent study published ... Ultraviolet-C light as a means of disinfection ... to reduce bioburden on anesthesia workstations. In the ... high-touch, complex medical equipment surfaces contaminated with three ... "This study further validates the body of ...
(Date:5/4/2017)... DIEGO , May 4, 2017  The American ... and Scientific Meeting— OBP Medical , a leading global ... the launch of a new extra-small size and first-in-market ... ER-SPEC vaginal specula. Already available in small, medium, ... makes OBP Medical,s line of single-use lighted specula the ...
Breaking Medicine Technology: